P. Ujhazy et al., EVIDENCE FOR THE INVOLVEMENT OF ECTO-5-NUCLEOTIDASE (CD73) IN DRUG-RESISTANCE, International journal of cancer, 68(4), 1996, pp. 493-500
Increased ecto-5'-nucleotidase (ecto-5'NT) protein expression in sever
al multidrug-resistant (MDR) cell lines, documented previously by our
group, suggests that this enzyme is involved in drug resistance. Here,
Northern blot analysis of selected cell lines and their MDR variants
positively correlated ecto-5'NT protein with its mRNA expression. An i
nhibitor of ecto-5'NT enzymatic activity, alpha,beta-methyleneadenosin
e 5'-diphosphate (AMP-CP), was used to determine if functionally activ
e enzyme had a role in drug resistance. AMP-CP (0.3 mM) reversed the r
esistance of ecto-5'NT-positive MDR cells (MCF7/AL, L1210/A) to doxoru
bicin, whereas it did not affect the doxorubicin sensitivity of the ec
to-5'NT-negative parental cell lines or that of 2 ecto-5'NT-negative M
DR cell lines (HL60/VCR and A2780/DX5). Furthermore, AMP-CP increased
rhodamine uptake and inhibited rhodamine efflux from ecto-5'NT-positiv
e MDR cells without affecting ecto-5'NT-negative MDR cells. The presen
ce of exogenous adenosine (0.5 mu M) circumvented AMP-CP-induced inhib
ition of rhodamine efflux from EL4/ADM cells. AMP-CP inhibited the gro
wth of the ecto-5'NT-positive L1210/A MDR cells but had no effect on t
he growth of the parental cell line. Determination of intracellular AT
P levels indicated that MDR cells which had increased ecto-5'NT expres
sion also had a lower intracellular ATP level than their parental cell
s. Our results suggest that, in certain MDR cell lines, ecto-5'NT serv
es as a required accessory molecule in resistance mediated by ATP-depe
ndent mechanisms and that growth-sustaining nucleosides are provided b
y this salvage pathway. (C) 1996 Wiley-Liss, Inc.